SCHEDULE 13G/A 0001887436 XXXXXXXX LIVE 3 Common Shares, no par value 08/14/2025 0001401040 DiaMedica Therapeutics Inc. 25253X207 Two Carlson Parkway Suite 260 Minneapolis MN 55447 Rule 13d-1(c) Trill AB V7 0.00 7764465.00 0.00 7764465.00 7764465.00 N 15.02 FI Jan Stahlberg V7 0.00 7764465.00 0.00 7764465.00 7764465.00 N 15.02 IN DiaMedica Therapeutics Inc. Two Carlson Parkway, Suite 260 Minneapolis, Minnesota 55447 This statement is filed by the entities and persons listed below, who are collectively referred to herein as "Reporting Persons," with respect to the Common Shares (as defined in Item 2(d) below) of the Company: Record Holder Trill AB is the record holder of the Common Shares. Reporting Individual Mr. Jan Stahlberg is the Board Member and beneficial owner of Trill AB. The address of the business office of each of the Reporting Persons is: Trill AB Sveavagen 17, 18th Floor SE-111 57 Stockholm, Sweden Citizenship is set forth in Row 4 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. Y Row 9 of each Reporting Person's cover page to this Schedule 13G sets forth the aggregate number of shares of securities of the Issuer beneficially owned by such Reporting Person as of the date of the event which requires filing of this statement and is incorporated herein by reference. Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentages of the securities of the Issuer beneficially owned by such Reporting Person as of the date of the event which requires filing of this statement and is incorporated herein by reference. The percentages are based on 51,688,913 shares of the Issuer's Common Stock outstanding as of August 8, 2025, as reported in the Issuer's quarterly report on Form 10-Q for the quarter ended June 30, 2025, filed with the Securities and Exchange Commission ("SEC") on August 12, 2025. The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Trill AB /s/ Jan Stahlberg 09/04/2025 Jan Stahlberg /s/ Jan Stahlberg 09/04/2025